Looking Back/Looking Forward: Heritage and Innovation in Dermatology
14 Nov 2024
Platinum Suite - Level 3
In this presentation we focus on the time period following the release of the innovative therapies Apoquel and Cytopoint into the veterinary market for treatment of canine allergic and atopic dermatitis. We will examine the evolution of treatment guidelines, understanding of allergic disease and the evidence base behind these groundbreaking products. We will also consider the importance of the Human Animal Bond and how effective therapy can positively impact this.
Learning Outcomes
-Understand the pathophysiology of canine allergic skin disease
-Study Guideline evolution around understanding and therapy of Canine Allergic Skin Disease
-Knowledge of the evidence base behind Apoquel and Cytopoint-what do we know 11 and 7 years on?